Reported in 25% to 95% of confirmed cases that required hospitalisation.[8]Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013 Sep;13(9):752-61.
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(13)70204-4/fulltext#seccestitle10
http://www.ncbi.nlm.nih.gov/pubmed/23891402?tool=bestpractice.com
[27]Omrani AS, Saad MM, Baig K, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14:1090-5.
http://www.ncbi.nlm.nih.gov/pubmed/25278221?tool=bestpractice.com
[32]Al-Abdallat MM, Payne DC, Alqasrawi S, et al. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014 Nov 1;59(9):1225-33.
https://academic.oup.com/cid/article/59/9/1225/419021
http://www.ncbi.nlm.nih.gov/pubmed/24829216?tool=bestpractice.com
Median time to invasive mechanical ventilation was 7 days in a cohort of 47 patients.[8]Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013 Sep;13(9):752-61.
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(13)70204-4/fulltext#seccestitle10
http://www.ncbi.nlm.nih.gov/pubmed/23891402?tool=bestpractice.com
Extracorporeal membrane oxygenation has been used in some cases; however, efficacy has not been confirmed.[27]Omrani AS, Saad MM, Baig K, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14:1090-5.
http://www.ncbi.nlm.nih.gov/pubmed/25278221?tool=bestpractice.com
[71]Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160:389-397.
http://annals.org/aim/article/1817260/clinical-course-outcomes-critically-ill-patients-middle-east-respiratory-syndrome
http://www.ncbi.nlm.nih.gov/pubmed/24474051?tool=bestpractice.com
Risk factors for severe disease include age ≥50 years, diabetes mellitus, end-stage renal disease, and obesity.[5]Shalhoub S, Farahat F, Al-Jiffri A, et al. IFN-alpha-2a or IFN-beta-1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother. 2015;70:2129-32.
http://www.ncbi.nlm.nih.gov/pubmed/25900158?tool=bestpractice.com
[8]Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013 Sep;13(9):752-61.
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(13)70204-4/fulltext#seccestitle10
http://www.ncbi.nlm.nih.gov/pubmed/23891402?tool=bestpractice.com
[9]Al-Tawfiq JA, Hinedi K, Ghandour J, et al. Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis. 2014 Jul 15;59(2):160-5.
https://academic.oup.com/cid/article/59/2/160/2895452
http://www.ncbi.nlm.nih.gov/pubmed/24723278?tool=bestpractice.com
[27]Omrani AS, Saad MM, Baig K, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14:1090-5.
http://www.ncbi.nlm.nih.gov/pubmed/25278221?tool=bestpractice.com
New or worsening respiratory symptoms within 1 week of presentation. Chest x-ray shows bilateral opacities.[75]World Health Organization. Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected. Interim guidance. Jan 2019 [internet publication].
https://www.who.int/publications/i/item/WHO-MERS-Clinical-15-1-Revision-1
High-flow oxygen (up to 50 mL/minute) is recommended in some patients, although mechanical ventilation and intubation is usually required.[75]World Health Organization. Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected. Interim guidance. Jan 2019 [internet publication].
https://www.who.int/publications/i/item/WHO-MERS-Clinical-15-1-Revision-1
Initially reported in a few case reports.[1]Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012 Nov 8;367(19):1814-20.
http://www.nejm.org/doi/full/10.1056/NEJMoa1211721#t=article
http://www.ncbi.nlm.nih.gov/pubmed/23075143?tool=bestpractice.com
[29]Memish ZA, Zumla AI, Al-Hakeem RF, et al. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med. 2013 Jun 27;368(26):2487-94.
https://www.nejm.org/doi/10.1056/NEJMoa1303729
http://www.ncbi.nlm.nih.gov/pubmed/23718156?tool=bestpractice.com
[135]Deenitchina SS, Ando T, Okuda S, et al. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry. Am J Nephrol. 1995;15:57-65.
http://www.ncbi.nlm.nih.gov/pubmed/7872366?tool=bestpractice.com
Has since been reported in 58% of critically ill patients in one study, and 26% of patients in one cohort.[71]Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160:389-397.
http://annals.org/aim/article/1817260/clinical-course-outcomes-critically-ill-patients-middle-east-respiratory-syndrome
http://www.ncbi.nlm.nih.gov/pubmed/24474051?tool=bestpractice.com
[136]Cha RH, Joh JS, Jeong I, et al. Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-CoV designated hospital. J Korean Med Sci. 2015;30:1807-1814.
https://synapse.koreamed.org/DOIx.php?id=10.3346/jkms.2015.30.12.1807
http://www.ncbi.nlm.nih.gov/pubmed/26713056?tool=bestpractice.com
Possibly due to the presence of dipeptidyl peptidase-4 (DPP4) receptors in renal epithelial cells.[137]Eckerle I, Muller MA, Kallies S, et al. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East respiratory syndrome (MERS) coronavirus infection. Virol J. 2013;10:359.
https://virologyj.biomedcentral.com/articles/10.1186/1743-422X-10-359
http://www.ncbi.nlm.nih.gov/pubmed/24364985?tool=bestpractice.com
Detection of the virus in urine samples has been previously documented.[134]Poissy J, Goffard A, Parmentier-Decrucq E, et al. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J Clin Virol. 2014;61:275-278.
http://www.ncbi.nlm.nih.gov/pubmed/25073585?tool=bestpractice.com
Occurs in a minority of patients late in the course of illness.
Underlying mechanism of action is unknown.
Usually presents with thrombocytopenia, prolonged coagulation profile, and circulatory collapse.[27]Omrani AS, Saad MM, Baig K, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14:1090-5.
http://www.ncbi.nlm.nih.gov/pubmed/25278221?tool=bestpractice.com
[32]Al-Abdallat MM, Payne DC, Alqasrawi S, et al. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014 Nov 1;59(9):1225-33.
https://academic.oup.com/cid/article/59/9/1225/419021
http://www.ncbi.nlm.nih.gov/pubmed/24829216?tool=bestpractice.com
[71]Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160:389-397.
http://annals.org/aim/article/1817260/clinical-course-outcomes-critically-ill-patients-middle-east-respiratory-syndrome
http://www.ncbi.nlm.nih.gov/pubmed/24474051?tool=bestpractice.com
Patients may require vasopressor and inotrope support.